Moon-Kyu Lee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Moon-Kyu Lee has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
- Kyong Soo Park
Division of Endocrinology and Metabolism, Department of Internal Medicine Konkuk University Medical Center Seoul Korea
3 shared publications - Dae Jung Kim
Department of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon, Korea
2 shared publications - Kun-Ho Yoon
Division of Endocrinology and Metabolism, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea
2 shared publications - Kwang-Won Kim
Department of Internal Medicine, Gachon University Gil Medical Center, Gachon University College of Medicine, Namdong-daero 774, Namdong-gu, Incheon 21565, South Korea
2 shared publications Myung-Shik Lee
2 shared publications- Bong Soo Cha
Department of Internal Medicine Yonsei University College of Medicine Seoul Republic of Korea
1 shared publication
Latest Publications
- 22 February 2016
- Published by Elsevier in Metabolism
- Vol. 65 (6) , 843-851
Increased postprandial apolipoprotein B-48 level after a test meal in diabetic patients: A multicenter, cross-sectional study
- 22 February 2016
- Published by Elsevier in Metabolism
- Vol. 65 (6) , 843-851
Increased postprandial apolipoprotein B-48 level after a test meal in diabetic patients: A multicenter, cross-sectional study
- 30 April 2008
- Published by Elsevier in Metabolism
- Vol. 57 (4) , 479-487
Effects of rosiglitazone on body fat distribution and insulin sensitivity in Korean type 2 diabetes mellitus patients
- 30 April 2008
- Published by Elsevier in Metabolism
- Vol. 57 (4) , 479-487
Effects of rosiglitazone on body fat distribution and insulin sensitivity in Korean type 2 diabetes mellitus patients
- 29 February 2008
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 79, S18
BS5-1 Thiazolidinediones stimulate GLUT-2, glucokinase and BETA2/NeuroD expression and regulate insulin secretion and synthesis
- 29 February 2008
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 79, S18
BS5-1 Thiazolidinediones stimulate GLUT-2, glucokinase and BETA2/NeuroD expression and regulate insulin secretion and synthesis
- 11 May 2007
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 77 (3) , S238-S242
N-terminal pro-brain natriuretic peptide (NT-proBNP) in Type 2 diabetes with left ventricular dysfunction
- 11 May 2007
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 77 (3) , S238-S242
N-terminal pro-brain natriuretic peptide (NT-proBNP) in Type 2 diabetes with left ventricular dysfunction
- Open Access
- 1 January 2005
- Published by Korean Medical Association in Journal of the Korean Medical Association
- Vol. 48 (12) , 1157-1164
Definition and Diagnosis of the Metabolic Syndrome
Bae SJ, et al. J Korean Med Assoc. 2005 Dec;48(12):1157-1164. http://dx.doi.org/10.5124/jkma.2005.48.12.1157
- 1 January 2005
- Published by Korean Medical Association in Journal of the Korean Medical Association
- Vol. 48 (12) , 1157-1164
Open AccessDefinition and Diagnosis of the Metabolic Syndrome
Bae SJ, et al. J Korean Med Assoc. 2005 Dec;48(12):1157-1164. http://dx.doi.org/10.5124/jkma.2005.48.12.1157
- 1 August 2000
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 42 (1-2) , 103-120
Cell transplantation for endocrine disorders
- 1 August 2000
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 42 (1-2) , 103-120
Cell transplantation for endocrine disorders
- 1 May 2000
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 85 (5) , 1801-1804
Significance of Pro12Ala Mutation in Peroxisome Proliferator-Activated Receptor-γ2 in Korean Diabetic and Obese Subjects*
Peroxisome proliferator-activated receptors (PPARs) are a nuclear hormone receptor superfamily of ligand-activated transcription factors, and the PPARγ subtype regulates adipocyte differentiation, lipid metabolism, and insulin sensitivity. There have been several reports on the relationship between the PPARγ2 Pro12Ala genotype and obesity or diabetes in Caucasians. The objective of this study was to examine the relationship between this mutation and obesity or diabetes in Korean subjects. Two hundred and twenty-nine Korean subjects, including 111 obese subjects (body mass index, >25 kg/m2) were included in this study. One hundred and eleven subjects had normal glucose tolerance, 60 had impaired glucose tolerance, and 58 had diabetes mellitus. We evaluated these subjects for the Pro12Ala mutation in the PPARγ gene using PCR-restriction fragment length polymorphism. Allele frequencies of the Pro12Ala missense mutation of PPARγ2 were not different among Korean subjects with normal glucose tolerance (qAla = 0.045), those with impaired glucose tolerance (qAla = 0.033), and those with diabetes mellitus (qAla = 0.043; P> 0.05). Allele frequencies of PPARγ2 Ala in obese subjects (qAla = 0.036) were not significantly different from those in nonobese subjects (qAla = 0.047). These results suggest that the Pro12Ala mutation in PPARγ is not associated with either diabetes or obesity and may not be an important determinant of obesity or diabetes in Korean subjects.
- 1 May 2000
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 85 (5) , 1801-1804
Significance of Pro12Ala Mutation in Peroxisome Proliferator-Activated Receptor-γ2 in Korean Diabetic and Obese Subjects*
Peroxisome proliferator-activated receptors (PPARs) are a nuclear hormone receptor superfamily of ligand-activated transcription factors, and the PPARγ subtype regulates adipocyte differentiation, lipid metabolism, and insulin sensitivity. There have been several reports on the relationship between the PPARγ2 Pro12Ala genotype and obesity or diabetes in Caucasians. The objective of this study was to examine the relationship between this mutation and obesity or diabetes in Korean subjects. Two hundred and twenty-nine Korean subjects, including 111 obese subjects (body mass index, >25 kg/m2) were included in this study. One hundred and eleven subjects had normal glucose tolerance, 60 had impaired glucose tolerance, and 58 had diabetes mellitus. We evaluated these subjects for the Pro12Ala mutation in the PPARγ gene using PCR-restriction fragment length polymorphism. Allele frequencies of the Pro12Ala missense mutation of PPARγ2 were not different among Korean subjects with normal glucose tolerance (qAla = 0.045), those with impaired glucose tolerance (qAla = 0.033), and those with diabetes mellitus (qAla = 0.043; P> 0.05). Allele frequencies of PPARγ2 Ala in obese subjects (qAla = 0.036) were not significantly different from those in nonobese subjects (qAla = 0.047). These results suggest that the Pro12Ala mutation in PPARγ is not associated with either diabetes or obesity and may not be an important determinant of obesity or diabetes in Korean subjects.